R Rampling
Impact in
Papers in
- Co-authors
- Donald M. Hadley (5 shared papers)Vakis Papanastassiou (4 shared papers)J. Harland (4 shared papers)Richard Petty (3 shared papers)James A. R. Nicoll (5 shared papers)M. Brown (2 shared papers)G. Cruickshank (5 shared papers)Matthew Fraser (2 shared papers)
- Journals
- British Journal of Cancer (7 papers)Clinical Oncology (4 papers)International Journal of Radiation Oncology*Biology*Physics (3 papers)Journal of Neuro-Oncology (3 papers)Gene Therapy (3 papers)
- Partner nations
- United KingdomItalyUnited States
In The Last Decade
R Rampling
47 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 105
- Genetics 704
- Genetics 1.0k
- Neurology 477
- Oncology 810
- Pathology and Forensic Medicine 359
Countries citing papers authored by R Rampling
This map shows the geographic impact of R Rampling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Rampling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Rampling more than expected).
Fields of papers citing papers by R Rampling
This network shows the impact of papers produced by R Rampling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Rampling. The network helps show where R Rampling may publish in the future.
Co-authors
The 25 scholars most cited alongside R Rampling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 478 | |
| 2 | 2004 | 258 | |
| 3 | 2002 | 255 | |
| 4 | 1994 | 242 | |
| 5 | 1987 | 159 | |
| 6 | A medical research council randomized trial in patients with primary cerebral non-Hodgkin lymphoma: cerebral radiotherapy with and without cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy. | 2000 | 143 |
| 7 | 2000 | 129 | |
| 8 | 1996 | 114 | |
| 9 | 1996 | 94 | |
| 10 | 1991 | 75 | |
| 11 | 1991 | 69 | |
| 12 | 2004 | 52 | |
| 13 | 1994 | 47 | |
| 14 | 1986 | 45 | |
| 15 | 1997 | 43 | |
| 16 | Phase I and pharmacokinetic study of tirapazamine (SR 4233) administered every three weeks. | 1997 | 39 |
| 17 | 2000 | 37 | |
| 18 | 1998 | 33 | |
| 19 | 1997 | 30 | |
| 20 | 1998 | 28 |
About R Rampling
R Rampling is a scholar working on Genetics, Neurology, Pulmonary and Respiratory Medicine, Epidemiology and Radiology, Nuclear Medicine and Imaging, having authored 49 papers that have together received 2.7k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (19 papers), Virus-based gene therapy research (8 papers), Herpesvirus Infections and Treatments (6 papers), CNS Lymphoma Diagnosis and Treatment (6 papers), Brain Metastases and Treatment (5 papers), Lymphoma Diagnosis and Treatment (5 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and Cancer, Hypoxia, and Metabolism (5 papers). The work is most often cited by research in Genetics (704 citations), Genetics (1.0k citations), Neurology (477 citations), Oncology (810 citations) and Pathology and Forensic Medicine (359 citations). R Rampling has collaborated with scholars based in United Kingdom, Italy and United States. Frequent co-authors include Donald M. Hadley, Vakis Papanastassiou, J. Harland, Richard Petty, James A. R. Nicoll, M. Brown, G. Cruickshank, Matthew Fraser, E. A. McKie and Paul Workman. Their work appears in journals such as British Journal of Cancer, Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics, Journal of Neuro-Oncology and Gene Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.